Abstract:For the immune system to function properly, the activation of leukocytes must be tightly regulated. Failures of immune control mechanisms underlie the aberrant targeting of self‐antigens (i.e. autoimmunity) and the collateral damage of healthy tissues during excessive responses to infectious threats or the unnecessary immune mobilization against innocuous commensal microbes. Foxp3‐expressing CD4+ Regulatory T cells (Tregs) are a major cellular force working to prevent these pathologies of immune dysregulation. These cells characteristically exhibit multiple suppressive function that is absolutely required for the maintenance of immune homeostasis. However, these cells can hamper desirable anti‐tumor immune responses in cancer patients. Accordingly, a relative abundance of Tregs in the tumor microenvironment (TME) is a negative prognostic factor in many cancers. Treg‐depleting or antagonizing strategies show promise as potential interventions capable of unleashing anti‐tumor immunity from suppression. The characteristic gene expression and suppressive function of Tregs depend considerably on the stable expression and activity of the transcription factor FOXP3. While transcriptional regulation of the Foxp3gene has been studied in depth, both the expression and function of this factor are also modulated at the protein level. However, the molecular players involved in posttranslational FOXP3 regulation are just beginning to be elucidated. We have found that in the absence of the E3 ligase TRAF6 Tregs were dysfunctional in vivo. In these studies, mice with Treg‐restricted deletion of TRAF6 were highly resistant to implanted tumors and displayed enhanced anti‐tumor immunity. We further determined that FOXP3 undergoes lysine‐63 linked (K63) ubiquitination at lysine 262, and this posttranslational modification was mediated by TRAF6. When deprived of TRAF6 activity or rendered insensitive to K63 ubiquitination, FOXP3 displayed aberrant, perinuclear accumulation and disrupted regulatory function. Thus, K63 ubiquitination by TRAF6 ensures proper localization of FOXP3 and facilitates the transcription factor's gene‐regulating activity in Tregs. These results implicate TRAF6 as a key, hitherto unappreciated posttranslational facilitator of FOXP3 stabilization and Treg suppressive function that may be targeted by novel tolerance‐breaking immunotherapies to improve anti‐tumor immunity and combat disease progression in cancer patients.This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

T cell development involves TRAF3IP3-mediated ERK signaling in the Golgi.

TRAF3 regulates the effector function of regulatory T cells and humoral immune responses.

TRAF3IP3 at the trans-Golgi network regulates NKT2 maturation via the MEK/ERK signaling pathway

TRAF3IP3, a novel autophagy up‐regulated gene, is involved in marginal zone B lymphocyte development and survival

TRAF3 regulates STAT6 activation and T helper cell differentiation by modulating the phosphatase PTP1B

TRAF3 regulation of proximal TLR signaling in B cells

Mekk3 Regulates Ifn-Gamma Production In T Cells Through The Rac1/2-Dependent Mapk Cascades

Metabolic Control of Regulatory T Cell Stability and Function by TRAF3IP3 at the Lysosome.

Trappc1 Deficiency Impairs Thymic Epithelial Cell Development by Breaking Endoplasmic Reticulum Homeostasis.

Thymic-specific Regulation of TCR Signaling by Tespa1

Targeted Disruption of TRAF3 Leads to Postnatal Lethality and Defective T-Dependent Immune Responses

Role of TRAFs in Signaling Pathways Controlling T Follicular Helper Cell Differentiation and T Cell-Dependent Antibody Responses

Protein-Protein Interactions in TRAF3

The E3 Ligase TRAF6 Directs FOXP3 Localization and Facilitates Treg Function Through K63‐type Ubiquitination

Role of Smad and Non-Smad Signals in the Development of Th17 and Regulatory T Cells (49.3)

TRAF3: a new component of the TLR-signaling apparatus.

The Roles of TRAF3 in Immune Responses.

TRAF3 Controls Activation of the Canonical and Alternative NFκB by the Lymphotoxin Beta Receptor

Glycogen synthase kinase-3 is essential for Treg development and function

Coordinate Regulation of TCR signaling, Notch, and Gata3 in T Cell Development (138.27)

TRAF3IP3 promotes glioma progression through the ERK signaling pathway